Why iBio Shares Are Trading Lower By Around 48%; Here Are 23 Stocks Moving Premarket
Gainers
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 71.3% to $0.7190 in pre-market trading after the company reported withdrawal of registration statement.
Reported Late Tuesday, iBio Announces Pricing Of $3.5M Underwritten Public Offering Of 3,365,385 Shares Of Common Stock At A Price Of $1.04/Share
iBio, Inc. (NYSEA: IBIO) ("iBio" or the "Company"), an AI-driven innovator of precision antibody immunotherapies, today announced the pricing of its previously announced underwritten public offering
iBio Announces Proposed Underwritten Public Offering; No Size Disclosed
iBio, Inc. (NYSEA: IBIO) ("iBio" or the "Company"), an AI-driven innovator of precision antibody immunotherapies, today announced it intends to offer and sell, subject to market and other conditions,
‘Now Eggs Are RATIONED: Sainsbury’s Sell Out, Wetherspoon Offers Customers Hash Browns, Sausage Or Onion Rings After Eggs Run Out As Lidl Shoppers Are Limited To Three Cartons Each’ – Daily Mail Reporting On Effects Of Avian Flu
Supermarkets are rationing eggs as shoppers reveal empty shelves and Wetherspoon replaces eggs | Daily Mail Online
Britons are apparently panic-buying eggs amid fears of supermarket
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 184 companies set new 52-week lows.
IBio Divesting CDMO Business and CGMP Biologics Manufacturing Facility, to Result in About 50% Annualized Cost Savings; Commenced Workforce Reduction of Approximately 60% of Current Company Staffing Levels
iBio, Inc. (NYSEA:IBIO) ("iBio" or the "Company") an AI-driven innovator of precision antibody immunotherapies, announces it is seeking to divest its contract development and manufacturing organization (iBio CDMO, LLC) in order to complete its transformation into an antibody discovery and development company.
